An Immunogenic Peptide in the A-box of HMGB1 Protein Reverses Apoptosis-induced Tolerance through RAGE Receptor

• Published in: The Journal of biological chemistry 2014-03, Vol.289 (11), p.7777-7786
• Main Authors: LeBlanc, Philippe M., Doggett, Teresa Ann, Choi, Jayoung, Hancock, Mark A., Durocher, Yves, Frank, Filipp, Nagar, Bhushan, Ferguson, Thomas A., Saleh, Maya
• Format: Article
• Language: English
• Subjects: Animals; Apoptosis; Candida - metabolism; Candidiasis - immunology; Caspase; Caspase 1 - metabolism; Dendritic Cells - microbiology; Fibroblasts - cytology; HMGB1 Protein - chemistry; Immune Tolerance; Immunity, Innate; Immunology; Inflammation; Inflammation - immunology; Innate Immunity; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptides - chemistry; Receptor for Advanced Glycation End Products; Receptor for Advanced Glycation End Products (RAGE); Receptors, Immunologic - metabolism; Recombinant Proteins - metabolism; Sepsis; Sepsis - immunology; Surface Plasmon Resonance; Tolerance
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1074/jbc.M113.541474

Apoptotic cells trigger immune tolerance in engulfing phagocytes. This poorly understood process is believed to contribute to the severe immunosuppression and increased susceptibility to nosocomial infections observed in critically ill sepsis patients. Extracellular high mobility group box 1 (HMGB1) is an important mediator of both sepsis lethality and the induction of immune tolerance by apoptotic cells. We have found that HMGB1 is sensitive to processing by caspase-1, resulting in the production of a fragment within its N-terminal DNA-binding domain (the A-box) that signals through the receptor for advanced glycation end products (RAGE) to reverse apoptosis-induced tolerance. In a two-hit mouse model of sepsis, we show that tolerance to a secondary infection and its associated mortality were effectively reversed by active immunization with dendritic cells treated with HMGB1 or the A-box fragment, but not a noncleavable form of HMGB1. These findings represent a novel link between caspase-1 and HMGB1, with potential therapeutic implications in infectious and inflammatory diseases. Background: The role of caspase-1 in regulating the immunogenic properties of HMGB1 has not been previously reported. Results: We have mapped a peptide in the A-box of HMGB1 that reverses tolerance through RAGE. Conclusion: Inflammasome signaling regulates the immunogenic activity of HMGB1. Significance: Immunogenic peptides within the HMGB1 A-box may be exploited to reverse immune tolerance in sepsis patients.